Incident Noninfectious Uveitis Risk after Immune Checkpoint Inhibitor Treatment.

Chang, Myung Soo; Lee, Seung Won; Kim, Sunyeup; Lee, Christopher Seungkyu; Byeon, Suk Ho; Kim, Sung Soo; Kim, Yong Joon

Chang, Myung Soo; Lee, Seung Won; Kim, Sunyeup; Lee, Christopher Seungkyu; Byeon, Suk Ho; Kim, Sung Soo; Kim, Yong Joon.

Afiliação

Chang MS; Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea.
Lee SW; Department of Precision Medicine, Sungkyunkwan University School of Medicine, Suwon, Korea.
Kim S; Department of Medical AI, Sungkyunkwan University School of Medicine, Suwon, Korea.
Lee CS; Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea.
Byeon SH; Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea.
Kim SS; Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea.
Kim YJ; Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea. Electronic address: kyjcolor@naver.com.

Ophthalmology ; 131(7): 867-869, 2024 Jul.

Article em En | MEDLINE | ID: mdl-38522600

Assuntos

Inibidores de Checkpoint Imunológico; Uveíte; Humanos; Uveíte/induzido quimicamente; Uveíte/tratamento farmacológico; Uveíte/diagnóstico; Inibidores de Checkpoint Imunológico/efeitos adversos; Incidência; Masculino; Feminino; Pessoa de Meia-Idade; Idoso; Fatores de Risco; Estudos Retrospectivos; Melanoma/tratamento farmacológico; Adulto

Palavras-chave

immune checkpoint inhibitor; skin melanoma; uveitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Uveíte / Inibidores de Checkpoint Imunológico Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google